查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571635

注射給藥裝置市場規模、佔有率和趨勢分析報告：按產品、治療應用、最終用途、地區和細分市場預測，2024-2030 年

Injectable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Therapeutic Use, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

注射給藥裝置市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球注射給藥器材市場規模預計將達到8,232.9億美元。

預計2024年至2030年該市場將以8.7%的複合年成長率成長。糖尿病和癌症等慢性疾病的增加增加了對注射給藥的需求。與其他傳統的藥物傳遞形式不同，注射劑繞過首過代謝，從而最大限度地提高藥物的生物有效性。隨著技術的進步，製造和銷售的設備都是量身定做的，以滿足患者的特定需求。

自行注射裝置的出現使得無需醫療協助即可自我注射藥物成為可能。生技藥品市場正在發生許多以技術為導向的開拓，進一步提高了這些注射裝置在具有挑戰性的疾病領域的適用性。自動注射器讓糖尿病患者可以使用自動注射器、筆和無針注射器來管理胰島素水平。

該市場的主要限制因素是針頭相關的傷害和感染疾病、監管報銷的模糊性、注射藥物的無菌性以及對其他毒性較小且更易於管理的藥物輸送系統的偏好。儘管有這些市場限制因素，注射給藥產品的市場潛力仍然巨大，大多數主要參與者選擇注射給藥而不是其他給藥形式。注射給藥產業依產品類型分為兩個子類型：自行注射裝置和傳統注射裝置。此外，根據治療應用，注射給藥產業分為自體免疫疾病、荷爾蒙疾病、腫瘤等。

根據最終用戶應用，注射給藥產業分為其他行業，包括醫院、家庭護理機構、研究設施、診斷和臨床實驗室。

注射給藥裝置市場報告亮點：

  • 預計腫瘤學在預測期內的複合年成長率將達到 9.3%。這是由於全球癌症發生率不斷上升以及標靶治療的進步。
  • 2023年市場佔有率為53.2%，以醫院為主。醫院擴大採用先進的注射設備，因為它們能夠提供快速的治療效果，這在急診醫學和危機情況下至關重要。
  • 2023年北美給藥裝置市場佔40.5%佔有率。北美有大量患有糖尿病、癌症和自體免疫疾病等慢性病的人口。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章注射給藥裝置市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 注射給藥裝置市場分析工具
    • 波特的分析
    • PESTEL分析

第4章注射給藥裝置市場：產品估算與趨勢分析

  • 細分儀表板
  • 注射給藥裝置市場：2023 年及 2030 年產品變化分析
  • 裝置
  • 配方

第5章注射給藥裝置市場：治療應用的估計與趨勢分析

  • 細分儀表板
  • 注射給藥裝置市場：2023 年和 2030 年治療應用變化分析
  • 自體免疫疾病
  • 荷爾蒙失調
  • 腫瘤學
  • 其他

第6章注射給藥裝置市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 注射給藥裝置市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 居家照護環境
  • 其他

第7章注射給藥裝置市場：區域估計與趨勢分析

  • 2023 年及 2030 年注射給藥裝置市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Baxter
    • Schott AG
    • BD
    • Eli Lilly and Company
    • Terumo Corporation
    • Elcam Medical
    • Unilife Corporation
    • Ypsomed AG
    • Gerresheimer AG
    • Sanofi
簡介目錄
Product Code: 978-1-68048-GVR-8

Injectable Drug Delivery Devices Market Growth & Trends:

The global injectable drug delivery devices market size is anticipated to reach USD 823.29 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.7% from 2024 to 2030. The increase in the number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first-pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.

With the advent of self-injection devices, injectable drugs can be self-administered without the need for medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.

The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with the majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.

The injectable drug delivery industry by end-user application is categorized into hospitals, home care settings, and others including research establishments, diagnostics, and clinical laboratories.

Injectable Drug Delivery Devices Market Report Highlights:

  • Oncology is anticipated to witness the fastest CAGR of 9.3% over the forecast period. This is due to the growing incidence of cancer globally and the evolution of targeted therapies.
  • Hospitals dominated the market with 53.2% share in 2023. Hospitals are increasingly adopting advanced injectable devices due to their ability to provide rapid therapeutic effects, which is crucial in emergency care and critical situations.
  • North America injectable drug delivery devices market dominated with 40.5% market share in 2023. North America has a significant population with chronic diseases such as diabetes, cancer, and autoimmune disorders.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Injectable Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Injectable Drug Delivery Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Injectable Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Injectable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Devices
    • 4.3.1. Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Self-injection Devices
      • 4.3.2.1. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Conventional Devices
      • 4.3.3.1. Conventional Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Formulations
    • 4.4.1. Formulations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Conventional Drug Delivery
      • 4.4.2.1. Conventional Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Novel Drug Delivery
      • 4.4.3.1. Novel Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Injectable Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Injectable Drug Delivery Devices Market: Therapeutic Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Autoimmune Disorders
    • 5.3.1. Autoimmune Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hormonal Disorders
    • 5.4.1. Hormonal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Injectable Drug Delivery Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Injectable Drug Delivery Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Homecare Settings
    • 6.4.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Injectable Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Injectable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Baxter
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Schott AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. BD
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Eli Lilly and Company
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Terumo Corporation
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Elcam Medical
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Unilife Corporation
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Ypsomed AG
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Gerresheimer AG
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Sanofi
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives